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Background: Human endogenous retroviruses of the HERV-K(HML-2) group have been associated with the
development of tumor diseases. Various HERV-K(HML-2) loci encode retrovirus-like proteins, and expression of such
proteins is upregulated in certain tumor types. HERV-K(HML-2)-encoded Rec and Np9 proteins interact with
functionally important cellular proteins and may contribute to tumor development. Though, the biological role of
HERV-K(HML-2) transcription and encoded proteins in health and disease is less understood. We therefore
investigated transcription specifically of HERV-K(HML-2) rec and np9 mRNAs in a panel of normal human tissues.
Results: We obtained evidence for rec and np9 mRNA being present in all examined 16 normal tissue types. A total
of 18 different HERV-K(HML-2) loci were identified as generating rec or np9 mRNA, among them loci not present in
the human reference genome and several of the loci harboring open reading frames for Rec or Np9 proteins. Our
analysis identified additional alternative splicing events of HERV-K(HML-2) transcripts, some of them encoding
variant Rec/Np9 proteins. We also identified a second HERV-K(HML-2) locus formed by L1-mediated retrotransposition
that is likewise transcribed in various human tissues.
Conclusions: HERV-K(HML-2) rec and np9 transcripts from different HERV-K(HML-2) loci appear to be present in various
normal human tissues. It is conceivable that Rec and Np9 proteins and variants of those proteins are part of the
proteome of normal human tissues and thus various cell types. Transcription of HERV-K(HML-2) may thus also have
functional relevance in normal human cell physiology.
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Retrotransposition, L1 elementBackground
Human endogenous retroviruses (HERVs) stem from an-
cient germ line infections by exogenous retroviruses.
About 8% of the human genome mass consists of retro-
viral sequences in sensu stricto and sequences with
retroviral portions. There are about 40 phylogenetically
distinct HERV groups documenting germ line integra-
tion, that is, provirus formations by different ancient ex-
ogenous retroviruses millions of years ago. Re-infections
and intracellular amplifications often increased numbers* Correspondence: jens.mayer@uks.eu
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unless otherwise stated.of proviruses per HERV group for limited evolutionary
time periods following initial integration events. Most
HERV groups no longer encode former retroviral pro-
teins due to long time presence in the genome and thus
accumulation of nonsense mutations including smaller
and larger indels. Some retroviral proteins, in particular
Envelope (Env), have been conserved during evolution
to contribute important Env-mediated functions such as
fusion of cell membranes [1-4].
The so-called HERV-K(HML-2) group (in short,
HML-2) includes a number of evolutionarily young pro-
viruses, some of which formed in the human lineage
after the evolutionary split of human from chimpanzee
about 6 million years ago. Especially the young HML-2
loci often harbor open reading frames (ORFs) for retro-
viral proteins such as Gag, Protease, Polymerase, andl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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identified typical retroviral splicing events generating an
env mRNA and a sub-spliced env mRNA, originally
named cORF and later re-named rec, with most of the
envelope coding sequence removed. Historically, HML-2
proviruses have been divided into type 2 loci, the tran-
scripts of which can be sub-spliced to rec mRNA, and
type 1 loci that lack a characteristic 292-bp sequence
located about 50 bp into the env coding sequence [5,6].
Lack of the 292-bp sequence in type 1 loci impairs sub-
splicing of env mRNA to rec mRNA because of lack of
the rec splice donor (SD) site located within the deleted
region. Instead, a SD site just upstream of the 292-bp
deletion is now employed in combination with a splice
acceptor (SA) site located at the 3′ end of env that is the
same SA for splicing of transcripts from type 1 and type
2 loci. Such spliced transcripts derived from HML-2 type
1 loci have been named np9 [7,8] (Figure 1).
Clinical relevance of HML-2 transcription and pro-
teins has been investigated in the context of various
human diseases. Especially germ cell tumors (GCT) dis-
play strongly upregulated HML-2 transcription and ex-
pression of HML-2 proteins already in early stages of
tumor development. GCT patients display strong antibody
titers against HML-2 Gag and Env proteins at the time of
tumor detection (reviewed in ref. [2]).
Both rec and np9 mRNA can encode proteins with
potentially important cellular functions that may be
relevant to disease development. HML-2 Rec protein is
basically a functional homologue of HIVRev protein
[9-13]. Nude mice transgenic for Rec protein develop
lesions reminiscent of testicular carcinoma in situ [14].
Rec protein was shown to interact with several func-
tionally relevant cellular proteins such as promyelocytic
zinc finger protein (PLZF), testicular zinc finger protein
(TZFP), Staufen-1, and human small glutamine-richFigure 1 Schematic of HERV-K(HML-2) provirus and splicing of rec an
generated by a second splicing event of env mRNA removing most of the
acceptor site just upstream of the 3′LTR. Because SD2 for rec mRNA is loca
alternative np9-specific SD2 is used instead also resulting in a translation fra
amplification of rec and np9 mRNA/cDNA is indicated. Note that the lowertetratricopeptide repeat protein (hSGT). Np9 protein
was shown to interact with PLZF and ligand of Numb
protein X (LNX). All of those interactions may have
important cellular consequences depending on cellular
context [15-20].
Several recent studies have identified a number of
HML-2 loci transcribed in various disease as well as nor-
mal conditions by assigning specifically generated HML-2
cDNA sequences to genomic HML-2 loci employing
characteristic sequence differences between HML-2 loci,
with transcription patterns varying considerably between
conditions (for instance, see [21-26]). Several of the
transcribed HML-2 loci can, in principle, encode rec or
np9 mRNA. We have previously analyzed HML-2 loci
specifically for coding capacity for rec mRNA and pro-
tein by analysis of HML-2 locus sequences for features
required for rec mRNA splicing and presence of a Rec
ORF within predicted mRNA sequences. We also had
identified a number of HML-2 loci generating rec
mRNA by means of cDNA sequence assignments to
genomic HML-2 loci [21,27].
The role(s) of HML-2 Rec and Np9 proteins in human
biology is still little understood. As various HML-2 loci
are also transcribed in normal human tissue types, it is
conceivable that HML-2 proteins also exert biological
functions apart from potential roles in disease devel-
opment. To contribute to a better understanding of a
potential biological relevance of HML-2 Rec and Np9,
we investigated presence of rec and np9 mRNA in a
collection of normal human tissue types and identi-
fied HML-2 loci generating rec and np9 mRNA. We
also identified additional HML-2 loci not present in
the human reference genome sequence and additional
splicing variants of HML-2 transcripts potentially en-
coding HML-2 protein variants in the course of our
studies.d np9 mRNAs. Irrelevant proviral regions are omitted. rec mRNA is
env gene region. Both rec and np9 mRNA utilize the same splice
ted within the 292-bp sequence missing in HML-2 type 1 proviruses, an
meshift when spliced to exon 3. Location of PCR primers used for
provirus map is not drawn to scale. LTR, long terminal repeat.
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Identification of HERV-K(HML-2) rec and np9 mRNA in
normal human tissues
Recent findings indicated transcription of HERV-K
(HML-2) loci in various human cell and tissue types.
Several proteins encoded by some HML-2 loci are
considered to be involved in the development of some
diseases, among them HML-2 Rec and Np9 proteins
in the development of certain tumor types. Carrying
on the identification of transcribed HERV and espe-
cially HML-2 loci in various disease and normal con-
ditions, we were now interested in whether there are
rec and np9 mRNAs in normal human tissues and, if
so, from which HML-2 loci those rec and np9 mRNAs
were generated.
To identify rec and np9 mRNA, we made use of a
multiple tissue cDNA panel that included cDNAs from
16 different tissue types (15 actual tissues and peripheral
blood leukocytes (PBL), henceforth all designated as
‘tissues’ for the sake of simplicity). We amplified rec and
np9 mRNA-derived cDNA by using PCR primers located
within exons 2 and 3 of HML-2 proviral full-length tran-
scripts (Figure 1) and considering sequence variations
between HML-2 loci within PCR primer binding regions
to compensate for potentially suboptimal amplification
of respective cDNAs.
PCR products of ca. 580 bp indicative of rec mRNA
could be amplified from all 16 tissue cDNAs, with
amplification from cDNA from PBL resulting in only
a faint band after gel electrophoresis. PCR products
of ca. 360 bp indicative of np9 mRNA could be ampli-
fied from all 16 tissue cDNAs as well, with amplification
from cDNA from PBL producing a relatively strong
PCR product (Figure 2). PCR products of ca. 1 kb amp-
lified from liver and testis cDNAs and ca. 2.2 kb ampli-
fied from spleen and thymus cDNAs were not further
regarded in this study. Taken together, rec and np9
mRNA appeared to be present in all tissue types examined
in this study.Figure 2 Gel electrophoretic separation of rec- and np9-specific PCR p
normal human tissues and peripheral blood leukocytes. Expected product
generated from GCT-derived Tera-1 cell line, known to strongly express HM
served as a positive control. ‘ctrl.’ indicates a PCR control reaction without
PBL is not properly reproduced. ‘n.a.’ indicates additional PCR products of a
the thymus not further investigated in this study.Identification of rec and np9 mRNA encoding HERV-K
(HML-2) loci
We then identified HML-2 loci having generated those
rec and np9 mRNAs. To do so, we cloned rec and np9
mRNA representing PCR products and sequenced in-
serts from randomly selected plasmid clones. We then
assigned resulting cDNA sequences, on average 41 (min.
29, max. 46) per tissue type, to specific HML-2 type 1
and type 2 loci in the human reference genome sequence
by means of characteristic sequence differences between
the various HML-2 loci. Despite the rather short-sized
PCR products, thus short cDNA sequences (excluding pri-
mer regions), there was a sufficient number of sequence
differences between relevant exon regions of HML-2 loci
for unambiguously assigning generated rec and np9 cDNA
sequences to loci. For rec mRNA-derived cDNAs, only
two HML-2 loci in chromosome 1 were identical in
sequence for the regarded exon regions, and respective rec
transcripts could thus, in principle, not be assigned to
either one of them (Additional file 1: Figure S1).
We identified rec transcripts originating from, in total,
nine different genomic HML-2 loci. Some tissue types
(lung and colon) appeared to contain rec mRNA from
up to five different HML-2 loci, while in kidney tissue,
rec transcripts originated from only one HML-2 locus.
Other tissue types displayed intermediate numbers of
transcribed rec mRNA coding loci. rec transcripts from
two HML-2 loci in chromosome 2q32.1 and 5q15 were
found in 15 and 13, respectively, of the examined tissues
(Table 1). As we will describe below, several of those loci
are special with regard to rec mRNA.
We identified np9 transcripts originating from, in
total, seven different HML-2 loci present in the human
reference genome sequence. As for rec mRNA, np9
mRNA originated from variable numbers of HML-2 loci
depending on tissue type. np9 mRNA transcripts from
HML-2 loci in chromosomes 1q22 and 3q12.3 were
found in 14 and 13, respectively, of the examined tissues
(Table 1). Two additional np9 mRNA encoding HML-2roducts amplified from a panel of cDNAs. Generated from 15
sizes were ca. 580 and 360 bp for rec and np9, respectively. cDNA
L-2 both on the RNA and protein level (for instance, see ref. [28]),
template DNA. A faint band representing rec-specific PCR product from
pprox. 1 kb in the liver and testis and approx. 2.2 kb in the spleen and
Table 1 Summary of absolute numbers of np9 and rec representing cDNA sequences assignable to HERV-K(HML-2) locia




Placenta Lung Liver Skeletal muscle Kidney
chr1:75615359-75621731 ERVK-1 1p31.1 1
chr1:153863081-153872260 ERVK-7 1q22 1 7 11 15 21 2 1
chr1:158927199-158936430 ERVK-18 1q23.3
chr3:102893427-102902549 ERVK-5 3q12.3 1 10 6 1 7 3 1 2
chr3:114225814-114234972 ERVK-3 3q13.2
chr4:166136289-166143518 - 4q32.3
chr22:17306187-17315361 ERVK-24 22q11.21 1
HERV-K111 16 6 10 5 2 2 5 6
Venter locus 1 13 1 6 2 3 4
Not assignable np9-like 15 25 7 3 4 2 12 4
chr2:187093879-187095344 ERVK-30 2q32.1 10 13 2 2 6 5 4 4
chr3:127091992-127101129 ERVK-4 3q21.2 1
chr5:30522516-30531962 - 5p13.3
chr5:92818136-92819668 ERVK-31 5q15 2 8 13 89 10 11 1
chr6:78483381-78492802 ERVK-9 6q14.1 1 15
chr7:4588583-4606557 ERVK-6 7p22.1 1
chr10:101570559-101577735 ERVK-17 10q24.2 1 8
chr12:57007509-57016965 ERVK-21 12q14.1 3 2 1 20
chr19:32820338-32829201 ERVK-27 19q12 2
Total # of sequences 46 85 42 101 43 43 41 42 37





chr1:153863081-153872260 1 22 11 4 7 10 8 6 24 Y
chr1:158927199-158936430 3 1 1 2




HERV-K111 1 2 2 1 3 4 11
Venter locus 15 5 13 5 3
Not assignable np9-like 5 2 4 12 3 8 5 4 18
rec
chr2:187093879-187095344 13 13 12 3 1 5 4 8 28 17
chr3:127091992-127101129 1 1 Y
chr5:30522516-30531962 1 Y
chr5:92818136-92819668 4 7 1 11 7 10 9 7 12
chr6:78483381-78492802 Y
chr7:4588583-4606557 1 2 Y
chr10:101570559-101577735 1 3 1 Y
chr12:57007509-57016965 1 1 1 1 Y
chr19:32820338-32829201 Y
Total # of sequences 42 45 36 44 29 39 41 44 88 43
aNormal tissue types from which cDNA sequences were generated are indicated on the top. Values in italics indicate results from experiments starting from total
RNA instead of pre-made cDNA specifically for heart, brain, and colon tissue (see paper text). HML-2 loci including chromosomal coordinates in the hg18 human
reference genome sequence are indicated in the left-most column, followed by HUGO Gene Nomenclature Committee (HGNC)-assigned locus designations [29]
and location in chromosomal bands. Total numbers of analyzed cDNA sequences per tissue are indicated at the bottom. np9-like cDNA sequences unambiguously
assignable to recently described HERV-K111 and Venter locus sequences not present in the human reference genome sequence (see text for details) are given
separately. np9-like cDNA sequences not assignable to any of the listed or other HML-2 type 1 locus sequences are also given separately. Presence of ORFs for
Np9 or Rec protein (‘Y’) in predicted mRNA sequences derived from the various HML-2 loci is indicated. See Figure 5 for actual protein sequences.
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sues and which are not present in the human reference
genome sequence, are described below.
Taken together, our results indicate that rec or np9
mRNA originated from at least 18 different HML-2 loci
in various normal human tissue types.
An additional HML-2 locus formed by L1-mediated
retrotransposition of rec mRNA
We have previously reported a HML-2 locus located in
chromosome 2q32.1 that was formed by L1-mediated
retrotransposition of a rec mRNA [21]. In the present
study, that locus was found to be transcribed in almost
all examined normal human tissues (Table 1). We now
identified an additional HML-2 locus located in chromo-
some 5q15 (hg18; chr5: 92818136–92819668), also tran-
scribed in almost all of the investigated tissues (Table 1),
that very likely was also formed by L1-mediated retro-
transposition of a rec mRNA. The 1.5-kb-long locus is
flanked by target site duplications (5′-TTAAAAATGT-3′)
typical of an L1 target site consensus sequence [30] with a
poly-A tail and a poly-A signal located (more) upstream of
the locus’ 3′ end. Apart from an approximately 250-bp 5′
truncation of the retrotransposed mRNA, portions typic-
ally missing from a full-length proviral HML-2 sequence
are those likewise not present in a rec mRNA and bound-
aries of missing sequence portions coincide with known
splice donor and acceptor sites of rec mRNA. Also, those
sites are basically identical with the ones of the retro-
transposed locus in chromosome 2q32.1. The locus in
chromosome 5q15 is evolutionarily old as it is also present
in the homologous genome regions of chimpanzee, gorilla,
orangutan, and gibbon, but missing in rhesus, baboon
(data not shown), and the common marmoset (Figure 3).
The latter, as a new world primate, is lacking HML-2
homologous sequences entirely. The locus in chromosome
5q15 does not encode a Rec(−like) protein due to a stop
codon 20 triplets into the coding sequence.
True transcription of two retrotransposed HML-2 loci
We employed for amplification of rec and np9 tran-
scripts a pre-made panel of cDNAs. As opposed to true
splicing events, the two retrotransposed HML-2 loci in
chromosomes 2q32.1 and 5q15 would produce identi-
cally sized PCR products when amplified from mRNA/
cDNA or genomic DNA. We were therefore concerned
that amplified PCR products assignable to those two loci
were due to traces of genomic DNA present in the pre-
made cDNAs, thus conceivably a false indication of
those two HML-2 loci being transcribed in the examined
tissues. To investigate this further, we generated cDNA
from commercially available total RNA from three nor-
mal human tissues, specifically heart, brain, and colon,
following own previously established protocols forrigorous DNA removal and including strict controls for
DNA contamination [21]. We assigned, on average, 91
cDNA sequences from each of the three tissue RNAs to
genomic HML-2 loci. Overall, when taking higher num-
bers of cDNA sequences generated per tissue into ac-
count, we obtained very similar numbers regarding
transcribed HML-2 loci when compared to the pre-
made cDNA panel, especially regarding cDNA se-
quences assignable to the loci in chromosomes 2q32.1
and 5q15 (Table 1). It thus appears that the two retro-
transposed HML-2 loci are truly transcribed in quite a
number of normal human tissue types.
In accord with an HUGO Gene Nomenclature Commit-
tee initiative [29], the two HML-2 loci in chromosomes
2q32.1 and 5q15 were designated ERVK-30 and ERVK-31,
respectively.
Transcription of HML-2 loci not present in the human
reference genome sequence
Generated cDNA sequences regularly included np9
mRNA-like sequences that could not be assigned to
HML-2 type 1 loci in the human reference genome
sequence. At first glance, one population of sequences
was most similar to the ERVK-5 locus in chromosome
3q12.3, yet almost all those sequences uniformly dis-
played eight different nucleotide positions to that locus.
Further analysis provided evidence that about half of
those cDNA sequences were very likely transcribed from
recently reported HERV-K(HML-2) loci not present in
the human reference genome sequence. Specifically, out
of 280 cDNA sequences deemed unassignable to HML-2
loci in the human reference genome, a subset of 76
cDNA sequences were identical to the recently reported
HERV-K111 sequence (GenBank acc. no. GU476554; ref.
[32]) along the comparable proviral regions and thus
were presumably transcribed from the HERV-K111
locus. Another subset of 71 cDNA sequences were iden-
tical to a recently reported, 4214-bp-long sequence entry
consisting of a partial HERV-K(HML-2) type 1 locus
(GenBank acc. no. ABBA01159463; ref. [33]) (DNA
donor: J. Craig Venter; henceforth named ‘Venter locus’)
and were thus most likely transcribed from the Venter
locus (Additional file 1: Figure S2). Another subset of 133
unassignable sequences was neither identical to HERV-
K111 nor the Venter locus.
A fourth cDNA sequence population was most similar
to the ERVK-18 locus in human chromosome 1q23.3,
yet uniformly displayed 25 differing nucleotides to that
locus. That sequence population harbored an additional
245 nt compared to the amplified np9 cDNA-derived PCR
product. The difference in length was due to a SD signal
located 252 nt downstream within the env gene region
and a different SA2 located 7 nt downstream from the ca-
nonical rec/np9 SA2 (see below). Also, those sequences
Schmitt et al. Mobile DNA  (2015) 6:4 Page 6 of 13lacked the 292-bp sequence discriminating HML-2 type 1
and type 2 loci, so that they cannot be interpreted as
rec-like mRNA transcribed from a HML-2 type 2 locus
(Figure 4). The sequences displayed between 2- and 5-nt
differences along the comparable 567 nt of cDNA se-
quence to the Venter locus and to HERV-K111. It is
conceivable that those 245-bp longer cDNA sequences,
compared to np9 mRNA, represent alternatively spliced
transcripts from HML-2 type 1 loci, potentially from se-
quence alleles of HERV-K111, several of which have been
reported recently [34], or an allele of the Venter locus, or
other hitherto unknown sequence or presence/absence
alleles of HML-2 loci, several of which were partially de-
scribed recently [35] (see also the Discussion section).Figure 3 A HML-2 locus in human chromosome 5q15 once formed by
sequence alignments of relevant regions of the HERV-K(HML-2.HOM) provir
sequence (GenBank acc. no. X72790; ref. [8]), a recently described retrotran
locus in human chromosome 5q15 are shown, depicting target site duplica
upstream of the 3′TSD of the chromosome 2q32.1 and 5q15 loci. See ref. [
(B) A dot plot matrix comparison of the chromosome 5q15 locus sequenc
sequence is shown with proviral regions indicated for the latter, likewise de
(C) Presence of the HML-2 locus in the homologous regions of human chr
gibbon, and lack in rhesus monkey (the homologous HML-2 locus also lack
generally lack HERV-K(HML-2) homologous sequences. LTR, long terminal reAll of the abovementioned sequences appeared to have
been spliced differently from np9 mRNA. Specifically,
the SA site of intron 2 (removing most of the envelope
coding region) was located 7 bp downstream from the
canonical rec and np9 mRNA SA2 site [7,8]. This was
most likely due to both HERV-K111 and the Venter
locus harboring a mutated SA2 (5′-TGTTAGTCTG-
3′→ 5′-TGTTGGTCTG-3′) and a SA signal located
7 bp downstream (5′-CTGCAGGTGT-3′) being used
instead (Figure 4).
Taken together, based on detected sequence similar-
ities, our analysis provided evidence for HERV-K111 and
the Venter locus being transcribed and encoding np9-
like mRNA in various normal human tissue types. It wasL1-mediated retrotransposition of rec mRNA. (A) Multiple
al sequence (GenBank acc. no. AF074086; ref. [31]), a rec mRNA
sposed rec mRNA in human chromosome 2q32.1 [21], and the HML-2
tions, rec-typical intron/exon boundaries and poly-A tails immediately
21] for a more detailed description of the chromosome 2q32.1 locus.
e (reverse complemented) with the HERV-K(HML-2.HOM) reference
picting the rec-typical proviral regions present for that HML-2 locus.
omosome 5q15 in the genomes of chimpanzee, gorilla, orangutan,
ing in baboon is not shown). Marmosets, as new world monkeys,
peat; SA, splice acceptor; SD, splice donor; TSD, target site duplication.
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or another HML-2 type 1 locus encodes an alternatively
spliced, 245-bp longer mRNA.
Coding capacity of rec and np9 mRNAs
We analyzed whether transcribed rec and np9(−like)
mRNAs also have potential to encode Rec and Np9
proteins. We have previously analyzed the capacity of
genomic HML-2 type 2 loci to encode Rec protein and
have identified a number of HML-2 loci encoding rec
mRNA [27]. We now analyzed in a similar fashion the
capacity of HML-2 type 1 loci to potentially encode Np9
protein by (i) presence of canonical SD and SA sites, (ii)
and an ORF for Np9 protein within the predicted mRNA
sequence. We identified a total of 12 HML-2 type 1 loci
to potentially produce a spliced mRNA and to harbor an
ORF for Np9 protein as previously reported in size [7].
Several of the resulting Np9 proteins displayed amino
acid differences compared among each other (Figure 5).
For instance, a Np9 protein potentially encoded by a
locus on chromosome 1 (hg18: 205875079–205879259)
would harbor a deletion of three amino acids and add-
itional amino acid differences overlapping with previ-
ously reported nuclear localization and LNX protein
interaction domains [27]. Other HML-2 type 1 loci
could potentially only encode Np9-like proteins about
ten or more amino acids shorter than full-length Np9,
or being similar to Np9 only within the N-terminal third
of a (shorter) protein. This is also the case for proteins
potentially encoded by HERV-K111 and the Venter locus
that are identical with the canonical Np9 protein sequence
only for the N-terminal 15 aa (Figure 5). Notably, several
of the potentially protein encoding HML-2 type 1 loci
were found transcribed in various normal human tissues.
Similar to our study from a decade ago [27], we re-
analyzed for the present study HML-2 type 2 loci poten-
tially encoding Rec protein by examining sequence
features required for the splicing of rec mRNA and the
translation of a Rec protein. Our re-analyses identified
ORFs for Rec protein presumably in up to 19 HML-2 type
2 loci, among them the two polymorphic HERV-K113 and
HERV-K115 loci [36]. Two other HML-2 loci on human
chromosome 4 (hg18: 4029946–4039536 and 9268677–
9278272) may potentially encode much longer, Rec-like
proteins if they were transcribed. Several other loci only
harbor (very) short Rec protein ORFs. The potential full-
length Rec proteins display various amino acid differences
when compared among each other (Figure 5). As for Np9,
several of the potentially Rec protein encoding loci were
found transcribed in various normal human tissues.
Discussion
Several lines of evidence suggest biological significance
of HERV-K(HML-2)-encoded proteins Rec and Np9 inthe development of tumor diseases, for instance, germ cell
tumors and melanoma (for reviews, see [2,37]). However,
biological roles of those proteins still need to be investi-
gated in much more detail. Since transcripts from several
HML-2 loci have been identified in non-tumor and even
normal tissues, it is also conceivable that Rec and Np9
exert biological roles in normal human tissues. We there-
fore investigated in this study whether there are rec and
np9 mRNA transcripts also in normal human tissues. Our
strategy for identification of such transcripts involved the
amplification of a PCR product encompassing the second
and third exons of rec and np9 mRNA. Sequence differ-
ences within primer binding regions were also considered
to potentially demonstrate transcripts from sequence-
diverged HML-2 loci (see also ref. [21]). Contrary to previ-
ous studies (for instance, see [21,38]), this study does not
allow for estimating relative transcript levels for different
HML-2 loci as rec and np9 mRNA representing PCR
products were isolated and cloned in a combined fashion
thus potentially falsifying relative frequencies of rec and
np9 mRNA-derived sequences and transcribed loci. It is
also conceivable that full-length transcripts from some
HML-2 loci are spliced more efficiently to rec or np9
mRNA than those from other loci. Nevertheless, higher
numbers of cDNA sequence derived from particular loci
may hint towards higher transcript levels or more efficient
splicing of full-length transcripts from those loci. Also,
amplified cDNA sequences do not fully document the
structure of the actual rec and np9 mRNA sequences as
we amplified exons 2 and 3 encompassing intron 2, disre-
garding exon 1 and intron 1 of rec and np9 mRNAs. It is
therefore, in principle, possible that for some HML-2 loci
transcript, regions outside of the examined regions
are spliced in some non-canonical way, though Rec
and Np9 protein coding regions appear to be spliced
properly (see also below).
Independent of that, rec and np9 mRNA appear to be
present in quite a number of human tissue types as
indicated by respective PCR products amplified from 16
normal human tissues investigated in this study.
Our assignments of rec and np9 cDNA sequences to
HML-2 loci also indicate that at least 18 different HML-2
loci can be transcribed in normal human tissues and very
likely encode rec or np9 mRNAs. Additional transcribed
loci encoding rec or np9 may be identified, and tissue-
specific patterns of such rec or np9 mRNA encoding loci
may be identified when much higher numbers of cDNA
sequences than in this study are assigned to HML-2 loci.
Our assignment of cDNA sequences to HML-2 loci
also lends support to peripheral blood leukocytes not
being the sole source of rec and np9 mRNAs in the
various tissues as all tissues would then have displayed a
PBL-typical basic pattern of transcribed HML-2 loci.
However, HML-2 loci identified as transcribed and
Figure 4 Excerpts from a multiple sequence alignment of an alternative exon from one or several HERV-K(HML-2) type 1 loci. The
utilized SD site for the np9 intron 2 (‘alt. SD’) is located more downstream compared to the canonical np9 SD2 (‘skipped SD’). The 3′ end of intron
2 is also located 7 nt more downstream compared to the canonical np9/rec mRNA SA2 (‘alt. SA’). Several sequences have been included for
comparison: canonically spliced ‘np9_mRNA’ and ‘Rec_mRNA’ [7,8], corresponding sequence portions from the HERV-K111 provirus [32], the
Venter locus (GenBank acc. no. ABBA01159463; ref. [33]), and the HERV-K(HML-2.HOM) (type 2) provirus (GenBank acc. no. AF074086; ref. [31])
(nt positions of that sequence are given as reference), HML-2 loci ERVK-5 and ERVK-18 in human chromosomes 3 and 1 (nt positions according to
hg18) as most closely related, yet, clearly different HML-2 proviruses (see the paper text). Most of the np9/rec intron 2 has been omitted from the
figure, as indicated. Nucleotide positions deviating from the consensus sequence of included sequences are highlighted in black. Enlarged
alignment regions shown at the bottom depict usage of a different SD2 site compared to np9 mRNA (left and center) and usage of a different
SA2 compared to rec and np9 mRNA. Note the mutated SA2 site (AG→ GG) in the HERV-K111 and Venter locus sequences (see the paper text). A
HERV-K(HML-2) provirus map with locations of ORFs is shown at the top. LTR, long terminal repeat; SA, splice acceptor; SD, splice donor.
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from locus patterns observed for the various tissues. As
tissues are always composed of various cell types, it re-
mains to be investigated which cell types in the regarded
tissues actually produce rec and np9 mRNAs. Different
scenarios are conceivable. For instance, some HML-2
loci may be transcribed and produce a subset of rec and/
or np9 mRNAs in some cell types within a particular
tissue, while other cell types within that tissue con-
tribute a different mRNA subset because of other
HML-2 loci being transcribed in those cells. The pro-
portions of HML-2 loci transcribed in different cell
types could differ considerably between tissue types.
Eventually, cell type-specific transcription patterns will
have to be established.
As for Rec and Np9 protein levels, it is currently not
known how efficiently rec and np9 mRNAs are trans-
lated into respective proteins, how stable those proteins
are in normal human cells, and whether there is protein
translated in one or the other tissue/cell type at all.Cell culture-based experiments demonstrated a rela-
tively stable HML-2 Rec protein with a half-life >8 h
[39]. Np9 protein seems much shorter-lived in cell culture
experiments [18,19]. Nevertheless, little appears to be
known about the expression of Rec and Np9 proteins in
normal and diseased conditions. Rec protein expression
was reported in some melanoma tissue samples, but not
in melanocytes or normal lymph nodes [40,41] and in nor-
mal synovial, rheumatoid arthritis, and osteoarthritis spec-
imens [42]. Np9 protein was identified in EBV-positive
Raji cells that are derived from a Burkitt’s lymphoma, and
in an EBV-transformed human lymphoblastoid cell line,
IB4 [43]. The detection of Rec and Np9 proteins was
accompanied in those studies by detection of rec and np9
mRNAs. Therefore, rec and np9 mRNAs present in nor-
mal human tissues imply presence of Rec and Np9 protein
in normal human tissues. However, specially designed
studies on Rec and Np9 protein levels, half-life, cellular
distribution, and so on, in normal human cells will be
required. Well-suited Rec- and Np9-specific antibodies
Figure 5 (See legend on next page.)
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Figure 5 Multiple sequence alignments of conceptual translations of HML-2 type 1 and type 2 Np9 and Rec ORFs. HML-2 loci potentially
encoding Np9 (A) or Rec (B) protein and loci encoding only shorter proteins are shown. Chromosomal positions are given for each locus with
respect to the human hg18 reference genome sequence. ‘Tr’ indicates that the locus was identified as transcribed in the present study. Protein
sequences of a previously identified Np9-encoding mRNA [7] and a Rec-encoding mRNA (GenBank acc. no. X72790; ref. [8]) are given on the top
of each alignment. Previously reported Np9 and Rec functional domains are indicated in each alignment. Full-length protein-encoding HML-2 loci
are given in chromosomal order followed by shorter Np9-like and Rec-like ORFs. Proteins encoded by type 1 loci HERV-K111 and the Venter locus
(see text) are included in the Np9 alignment. Amino acid positions different among each other are highlighted. NES, nuclear export signal; NLS,
nuclear localization sequence; PLZF, promyelocytic zinc finger protein; TZFP, testicular zinc finger protein.
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blot and immunohistochemistry and immunocytochem-
istry for examination of tissue and cellular distributions,
respectively. It seems unclear whether current Rec and
Np9 antibodies will be fully suited for such studies espe-
cially when considering that several HML-2 protein vari-
ants with amino acid sequences and protein sizes very
similar to Rec and Np9 proteins have been described re-
cently (for instance, see [21,39]) and in this study.
Our analysis of transcribed HML-2 loci furthermore
identified two loci (designated ERVK-30 and ERVK-31),
both once formed by retrotransposition of rec mRNA by
L1 machinery, as transcribed in normal human tissues.
Locus ERVK-30, located in chromosome 2q32.1, has already
been described before [21]. The present study identified
another such locus, ERVK-31, located in chromosome
5q15, that is due to L1-mediated retrotransposition as it
displays typical hallmarks of that process and is identical
regarding exon-intron junctions compared to the ERVK-
30 locus in 2q32.1 and rec mRNA. The ERVK-31 locus in
chromosome 5q15, located central within a ~57-kb intron
of the NR2F1 antisense RNA 1 (NR2F1-AS1) gene produ-
cing a non-coding RNA, is about as evolutionarily old as
the ERVK-30 locus in 2q32.1; none of the two loci is
present in the homologous regions of the rhesus monkey
and baboon genomes but both homologous loci are
present in the genomes of subsequent primate species.
Evidence for both loci being transcribed was not due
to artifactual amplification from contaminating DNA po-
tentially still present in employed cDNA tissue panels, as
demonstrated by our control experiments from total
RNA from three selected normal tissues. Sequence data
from, for instance, the ENCODE project provide add-
itional support for the retrotransposed rec mRNA loci
ERVK-30/2q32.1 and ERVK-31/5q15 being transcribed.
Numerous single-pass and paired-read RNA-seq reads
generated from various cell lines and normal cell types
were mapped to the two loci’s sequence portions (data
not shown; ref. [44]). We thus describe here the sec-
ond instance of a HML-2 rec mRNA that was retro-
transposed by L1 machinery and is now transcribed
by a hitherto unknown promoter active in many hu-
man tissues. Contrary to the retrotransposed rec mRNAlocus in chromosome 2q32.1, the locus in chromosome
5q15 does not appear to encode a Rec-like protein as
it harbors a stop mutation about 20 triplets and a
frameshift about 63 triplets into the Rec coding
sequence.
Our study presumably identified in various human
tissues transcripts from two recently described HML-2
loci that are not present in the human reference genome
sequence. One population of np9 cDNA sequences was
identical to the recently described HERV-K111 provirus
[32]; another population of np9 cDNA sequences was
identical to sequence portions in GenBank acc. no.
ABBA01159463, a sequence identified in the genome of
J. Craig Venter, that consists of HML-2 pol, env, and 3′
long terminal repeat (LTR) sequence portions, starting at
ca. nt 5000 relative to the HERV-K(HML-2.HOM) pro-
viral sequence (GenBank acc. no. AF074086.2; ref. [31]).
Notably, transcripts from both loci employed a SA2
site located 7 nt downstream from the canonical SA2
site due to a mutation within that site. Transcripts
assignable to the HERV-K111 provirus were identified
in our study in all but four of the investigated normal
tissue types including lack of detection of HERV-K111
transcript in PBL. The HERV-K111 provirus was previ-
ously reported to be specifically active during HIV infec-
tion [32].
Transcripts from the ‘Venter locus’ were identified in
11 of the investigated tissues. Since several of the
employed tissue cDNA panels were pools from higher
numbers of donors, it seems less likely that lack of tran-
scripts in several tissues is due to a polymorphic pres-
ence/absence status of the HERV-K111 and the Venter
locus in respective tissues. In any case, more detailed
analyses will be required to characterize especially the
status, genome location, and exact sequence of the
Venter locus. We note in this context that numerous
sequence variants of HERV-K111 were recently reported
[34]. The Venter locus sequence displays 35-nt differ-
ences to HERV-K111 along 4.178 kb of comparable se-
quence and only 1-nt difference along the amplified
cDNA sequence portion. While the sequence of the
Venter locus is not identical to any of the reported
HERV-K111 variants (data not shown), it is nevertheless
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scribed variant of HERV-K111.
Additional analyses will also be required to identify
the HML-2 source locus (or loci) producing an alterna-
tively spliced, HML-2 type 1 locus-derived mRNA that
utilizes a splice donor site located 252 nt downstream
from the canonical np9 mRNA’s SD2 and thus resulting
in a longer mRNA. The isolated cDNA sequences dis-
play an open reading frame of 408 nt, starting at nt 41
of the cDNA sequences (nt 6805 relative to the HERV-K
(HML-2.HOM) sequence, GenBank acc. no. AF074086),
encoding a 135 aa long protein identical to HML-2 Env
along the N-terminal 80 aa. Since our employed forward
PCR primer overlapped with the start codon of the Env,
Rec, and Np9 ORFs, we currently do not have informa-
tion as to whether the source locus of the alternative
splice variant has a start codon identical to the start
codon of Env/Rec/Np9 proteins. That is, the ORF may
extend further upstream from the start codon at nt 41 of
the available cDNA sequence up to the Env/Rec/Np9
canonical start codon.
In this context, we also obtained cDNA sequence
evidence for splicing of transcripts from a previously
characterized HML-2 locus in human chromosome 10
very likely formed by reverse transcription and integra-
tion of a HML-2 transcript lacking env gene portions
[21]. Testis- and colon-derived cDNA sequences in-
cluded one sequence each lacking a 334-nt sequence
compared to full-length cDNA sequences from that
chromosome 10 locus. The missing sequence portion
was compatible with that sequence being a spliced out
intron. The resulting protein from that splice variant
would encode a chimeric protein consisting of Rec and
Np9 portions (Additional file 1: Figure S3).
Conclusions
Our study demonstrates HERV-K(HML-2) rec and np9
transcripts from various HML-2 loci in various normal
human tissues. Among them are Rec or Np9 protein
coding loci and it is thus conceivable that Rec and Np9
proteins might be present in normal human tissues. Rec/
Np9/Env-like proteins potentially encoded by retrotran-
sposed HERV-K(HML-2) loci identified recently and in
this study may also be present in various normal tissues.
Besides potential roles in disease development, it seems
worthwhile hypothesizing that various HERV-K(HML-
2)-encoded proteins exert biological functions also in
normal human tissues. Better knowledge of specific
HERV-K(HML-2) loci encoding rec and np9 mRNAs in
the various human tissue-composing cell types and
knowledge of amounts of Rec and Np9 protein present
in those cell types will likely contribute to a better un-
derstanding of those proteins’ functions under normal
cellular conditions.Methods
Multiple tissue cDNA panel and tissue total RNAs
We utilized the Human MTC™ Panel I and II (Clontech/
Takara Bio, Otsu, Japan). The two panels included nor-
malized, first-strand cDNA preparations from RNA
from, in total, 15 different normal human tissues and
peripheral blood leukocytes. cDNAs for each tissue con-
sisted of pools from 3 to 98 Caucasian individuals and
550 male/female Caucasians in the case of peripheral
blood leukocytes. Lung and liver derived cDNAs were
from one male Caucasian each.
We also utilized commercially available total RNA
from normal human heart, brain, and colon tissues
(Clontech/Takara Bio; catalogue numbers 636532;
636530; 636553).
Amplification of np9 and rec PCR products, cloning of PCR
products, plasmid preparation, sequencing
We amplified rec and np9 mRNA representing PCR
products from tissue cDNA panels employing forward
primers rec-np9-for-1: 5′-ATG AAC CCA TCA GAG
ATG CAA-3′; rec-np9-for-2: 5′-ATG AAT CCA TCA
GAG ATG CAA-3′; rec-np9-for-3: 5′-GCG AAC CCT
TCA GAG ATG CAA-3′; rec-np9-for-4: 5′-ATG AAC
CCA TCG GAG ATG AAA-3′; that were combined in a
ratio of 85/5/5/5, and reverse primers rec-np9-rev-1: 5′-
AGC ATC TGT TTA ACA AAG CA-3′; rec-np9-rev-2:
5′-AGC ATG TTT AAC AAA GCA-3′ 5% combined in
a ratio of 95/5. The various primer variants considered
sequence differences of HERV-K(HML-2) loci within
primer binding regions. PCR products were amplified
using standard conditions with AmpliTaq Gold (Applied
Biosystems/Life Technologies, Carlsbad, CA, USA) DNA
polymerase and the following PCR program: 12 min 95°C;
35 cycles: 50 s 95°C, 50 s 58°C, 30 s 72°C, and final elong-
ation 10 min 72°C. PCR products were separated by agar-
ose gel electrophoresis; np9 and rec representing PCR
products were purified from gels using NucleoSpin Gel
and PCR Clean-Up Kit (Macherey-Nagel GmbH & Co.
KG, Düren, Germany). Products were cloned into pCR II-
TOPO (Invitrogen/Life Technologies) and transformed
into Escherichia coli DH-5α cells. Plasmid DNA from
randomly selected bacterial colonies was purified and
subjected to Sanger sequencing (see below).
We amplified rec and np9 mRNA representing cDNA
from total RNA from heart, brain, and colon tissues by
RT-PCR following a previously established procedure
[21]. PCR products were cloned into pGEM T-Easy
(Promega GmbH, Mannheim, Germany). Plasmid DNA
from randomly selected bacterial colonies was prepared
as described before [32].
cDNA inserts were sequenced using vector-specific T7
primer and an Applied Biosystems 3730 DNA-Analyzer
(Seq-IT GmbH, Kaiserslautern, Germany). Sequence
Schmitt et al. Mobile DNA  (2015) 6:4 Page 12 of 13qualities were verified by eye, and poor quality sequence
reads were excluded from further analysis.
Chromosomal assignment of cDNA sequences
We assigned rec and np9 representing cDNA sequences
to specific HML-2 loci by sequence comparisons essen-
tially as described before [21,31]. Sequences that could
be unambiguously assigned to a HML-2 locus in the
human reference genome sequence with less than three
mismatches were considered for analysis. Sequences not
matching a locus in the human reference genome se-
quence are described in the main text. For assignment of
np9 cDNA sequences, we omitted the rather short
(23 nt when excluding primer binding region) and
thus little informative exon 2 of np9 mRNA (SA1 - SD2)
because the remaining sequence portions provided a
sufficient number of sequence differences between (type 1)
loci (see Additional file 1: Figure S1).
Analysis of HML-2 loci for np9 mRNA coding capacity
Similar to a recent analysis of HML-2 rec coding
capacity [27], we examined in a multiple alignment of
genomic HML-2 sequences, plus polymorphic HML-2
proviruses not present in the human reference genome
sequence, features required for np9 mRNA splicing and
Np9 protein coding capacity, specifically presence of 5′
and 3′LTRs, splice donor and acceptor sites, and open
reading frames as previously described [7].
Availability of supporting data
LN624403 and LN624404 are accession numbers of
cDNA sequences assignable to two HML-2 loci in hu-
man chromosomes 2q32.1 and 5q15 reported in this
study and previously [21]. Accession numbers LN680257
to LN680271 are 245 bp longer, np9-like cDNA se-
quences. Sanger sequence reads generated in the course of
this study have been deposited at the European Nucleotide
Archive (study accession number PRJEB8273).
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